Bipartisan Lawmakers Seek $10 Million for Psychedelics Research in Defense Bill

Bipartisan support for psychedelic medicine is hitting a new high on Capitol Hill. A cross-party coalition of lawmakers is currently pushing for an extra $10 million to fund Department of Defense clinical trials into substances like psilocybin and ibogaine. Led by Rep. Morgan Luttrell, a Navy SEAL veteran who has been open about his own success with these treatments, the effort aims to broaden research for active-duty military members. This follows a growing wave of support from high-profile figures like Newt Gingrich and HHS Secretary RFK Jr., who are all eyeing psychedelics as a potential breakthrough for mental health and trauma recovery.

For the cannabis community, this is a massive win because it continues to break down the federal "war on drugs" mentality. While the focus here is on psychedelics for veterans, any progress in researching alternative plant medicines helps normalize the entire industry. It proves that the government is finally starting to value therapeutic potential over outdated stigmas, which ultimately paves the way for better access and research for all natural medicines.